Cargando…
A Preclinical Study of Casein Glycomacropeptide as a Dietary Intervention for Acute Mania
BACKGROUND: Casein glycomacropeptide is a peptide that lacks phenylalanine, tyrosine, and tryptophan. This profile may enable it to deplete phenylalanine, tyrosine, and tryptophan, and subsequently the synthesis of dopamine and serotonin in the brain. Dopamine- and serotonin-depleting amino acid mix...
Autores principales: | Liebenberg, Nico, Jensen, Erik, Larsen, Erik Roj, Kousholt, Birgitte Saima, Pereira, Vitor Silva, Fischer, Christina Weide, Wegener, Gregers |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932479/ https://www.ncbi.nlm.nih.gov/pubmed/29726996 http://dx.doi.org/10.1093/ijnp/pyy012 |
Ejemplares similares
-
Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
por: Daly, Anne, et al.
Publicado: (2021) -
Influence of Glycomacropeptide on Rehydration Characteristics of Micellar Casein Concentrate Powder
por: Panthi, Ram R., et al.
Publicado: (2021) -
Reporting of 3Rs Approaches in Preclinical Animal Experimental Studies—A Nationwide Study
por: Kousholt, Birgitte S., et al.
Publicado: (2023) -
The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model
por: Ahring, Kirsten K., et al.
Publicado: (2022) -
Reporting quality in preclinical animal experimental research in 2009 and 2018: A nationwide systematic investigation
por: Kousholt, Birgitte S., et al.
Publicado: (2022)